Notice: This company has been marked as potentially delisted and may not be actively trading. Ocean Biomedical (OCEA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOptions ChainShort InterestTrends OCEA vs. OTEC, MIST, ANIX, MNOV, KPTI, ANL, NVCT, ANVS, ASMB, and ORMPShould you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include OceanTech Acquisitions I (OTEC), Milestone Pharmaceuticals (MIST), Anixa Biosciences (ANIX), MediciNova (MNOV), Karyopharm Therapeutics (KPTI), Adlai Nortye (ANL), Nuvectis Pharma (NVCT), Annovis Bio (ANVS), Assembly Biosciences (ASMB), and Oramed Pharmaceuticals (ORMP). Ocean Biomedical vs. OceanTech Acquisitions I Milestone Pharmaceuticals Anixa Biosciences MediciNova Karyopharm Therapeutics Adlai Nortye Nuvectis Pharma Annovis Bio Assembly Biosciences Oramed Pharmaceuticals Ocean Biomedical (NASDAQ:OCEA) and OceanTech Acquisitions I (NASDAQ:OTEC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability. Is OCEA or OTEC more profitable? Company Net Margins Return on Equity Return on Assets Ocean BiomedicalN/A N/A N/A OceanTech Acquisitions I N/A N/A -8.58% Does the media favor OCEA or OTEC? In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled OceanTech Acquisitions I'saverage media sentiment score. Company Overall Sentiment Ocean Biomedical Neutral OceanTech Acquisitions I Neutral Which has more volatility & risk, OCEA or OTEC? Ocean Biomedical has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, OceanTech Acquisitions I has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. Which has stronger earnings & valuation, OCEA or OTEC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOcean BiomedicalN/AN/A-$960KN/AN/AOceanTech Acquisitions IN/AN/A$1.97MN/AN/A Do institutionals and insiders hold more shares of OCEA or OTEC? 24.6% of Ocean Biomedical shares are held by institutional investors. Comparatively, 15.3% of OceanTech Acquisitions I shares are held by institutional investors. 73.5% of Ocean Biomedical shares are held by company insiders. Comparatively, 68.0% of OceanTech Acquisitions I shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor OCEA or OTEC? Ocean Biomedical received 4 more outperform votes than OceanTech Acquisitions I when rated by MarketBeat users. CompanyUnderperformOutperformOcean BiomedicalOutperform Votes4100.00% Underperform VotesNo VotesOceanTech Acquisitions IN/AN/A SummaryOcean Biomedical beats OceanTech Acquisitions I on 5 of the 6 factors compared between the two stocks. Ad Desko DigitalCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! Get Ocean Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OCEA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCEA vs. The Competition Export to ExcelMetricOcean BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.70M$6.58B$5.14B$8.84BDividend YieldN/A8.11%5.08%4.07%P/E RatioN/A11.01127.0917.62Price / SalesN/A363.611,227.0985.56Price / CashN/A52.5940.1336.27Price / Book-0.3210.176.936.36Net Income-$960,000.00$153.60M$119.36M$225.88M Ocean Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCEAOcean BiomedicalN/A$0.71+2.9%N/A-32.3%$24.70MN/A0.00N/AOTECOceanTech Acquisitions IN/A$11.75flatN/AN/A$41.09MN/A0.004MISTMilestone Pharmaceuticals2.3882 of 5 stars$1.85-0.5%$12.00+548.6%-28.3%$98.66M$1M-2.3030ANIXAnixa Biosciences2.8615 of 5 stars$3.06+0.7%$7.00+128.8%+5.5%$98.47M$210,000.00-7.855Analyst ForecastMNOVMediciNova0.6693 of 5 stars$2.00+2.6%N/A+7.5%$98.10M$1M-9.2910KPTIKaryopharm Therapeutics3.9654 of 5 stars$0.77-1.3%$5.00+550.2%+4.2%$97.12M$148.44M-0.67380ANLAdlai Nortye2.9315 of 5 stars$2.61+1.2%$9.00+244.8%-74.4%$96.31M$5M0.00127NVCTNuvectis Pharma3.3156 of 5 stars$4.96-2.2%$21.00+323.4%-38.9%$95.83MN/A-4.118ANVSAnnovis Bio1.8633 of 5 stars$6.79+3.8%$32.17+373.7%+2.9%$93.70MN/A-1.523ASMBAssembly Biosciences4.1619 of 5 stars$14.72-2.0%$35.00+137.8%+87.8%$93.62M$7.16M0.00100Gap DownHigh Trading VolumeORMPOramed Pharmaceuticals1.4728 of 5 stars$2.31+2.2%N/A+7.9%$93.12M$1.34M4.5310 Related Companies and Tools Related Companies OTEC Alternatives MIST Alternatives ANIX Alternatives MNOV Alternatives KPTI Alternatives ANL Alternatives NVCT Alternatives ANVS Alternatives ASMB Alternatives ORMP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OCEA) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocean Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
